Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 October 2024 | Story Jacky Tshokwe | Photo Bram Fischer
BRAM FISCHER MEMORIAL LECTURE 2024

Join us as Prof Premesh Lalu from the University of the Western Cape presents this year’s lecture, with a response from Prof Steven Friedman of the University of Johannesburg.

Lecture title: "Bram Fischer's Briefcase: What's Left of Apartheid?"

In a compelling narrative of historical irony, a briefcase exchanged between Bram Fischer and Sydney Kentridge after the Rivonia Trial was later reimagined in the 1997 theatre production Ubu and the Truth Commission, created by Jane Taylor, William Kentridge, and Handspring Puppet Company. Repurposed as the ‘Dogs of War’ puppet, this briefcase transformed into Brutus, Brutus, and Brutus – embodying apartheid’s enforcers and the unspoken tensions beneath South Africa's political history. Through the theatre lens, the lecture will explore whether Bram Fischer’s briefcase revealed apartheid as a tragicomedy that needed dismantling to foster genuine reconciliation.

Date: Thursday 14 November 2024
Time: 18:00 to 21:00

Venue: Albert Wessels Auditorium, UFS Bloemfontein Campus

Click to view documentClick here to RSVP before by 10 November 2024.

The Speaker

Prof Premesh Lalu is a prominent researcher and former Director of the Centre for Humanities Research (CHR) at the University of the Western Cape, which was awarded flagship status by the Department of Science and Innovation (DSTI) and the National Research Foundation (NRF) in 2016. His books include The Deaths of Hintsa: Post-Apartheid South Africa and the Shape of Recurring Pasts (2009) and Undoing Apartheid (2022). He is a respected voice in publications such as History and Theory, the Journal of Southern African Studies, and Critical Times, and serves on various international advisory boards.

The Respondent

Prof Steven Friedman is a Research Professor in the Faculty of Humanities at the University of Johannesburg. A widely published authority on South Africa’s democratic transition, his work focuses on democratic theory and practice. His notable publications include Good Jew, Bad Jew: Racism, Anti-Semitism and the Assault on Meaning, and he writes a weekly column, Against the Tide, offering critical insights into South African democracy.

For further information, please contact Alicia Pienaar at pienaaran1@ufs.ac.za.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept